A roadmap for the standardization of hemoglobin A2

Barrett, 2017, Thalassaemia screening and confirmation of carriers in parents, Best Pract. Res. Clin. Obstet. Gynaecol., 39, 27, 10.1016/j.bpobgyn.2016.10.015 Mosca, 2009, The role of haemoglobin A2 testing in the diagnosis of thalassaemias and related haemoglobinopathies, J. Clin. Pathol., 62, 3, 10.1136/jcp.2008.056945 Giambona, 2009, The significance of the hemoglobin A2 value in screening for hemoglobinopathies, Clin. Biochem., 42, 1786, 10.1016/j.clinbiochem.2009.06.026 HbVar. A database of human hemoglobin variants and thalassemia mutations. http://globin.cse.psu.edu/hbvar/menu.html. Weatherall, 2010, The inherited diseases of hemoglobin are an emerging global health burden, Blood, 15, 4331, 10.1182/blood-2010-01-251348 Galanello, 2010, Beta thalassemia, Orphanet J. Rare Dis., 5, 11, 10.1186/1750-1172-5-11 Paleari, 2017, On behalf of the IFCC working group on standardization of hemoglobin A2 (WG-HbA2), developing a reference system for the IFCC standardization of HbA2, Clin. Chim. Acta, 467, 21, 10.1016/j.cca.2016.05.023 Paleari, 2007, External quality assessment of hemoglobin A2 measurement: data from an Italian pilot study with fresh whole blood samples and commercial HPLC-systems, Clin. Chem. Lab. Med., 45, 88, 10.1515/CCLM.2007.002 Stephens, 2012, On behalf of the International Council for the Standardisation of Haematology (ICSH), ICSH recommendations for the measurement of haemoglobin A2, Int. J. Lab. Hem., 34, 1, 10.1111/j.1751-553X.2011.01368.x Paleari, 2018, Standardization of the HbA2 assay, eJIFCC, 29, 298 In vitro diagnostic medical devices — Requirements for establishing metrological traceability of values assigned to calibrators, trueness control materials and human samples. International standard ISO 17511:2020 (E). Arsene, 2018, On behalf of the IFCC Working Group on Standardisation of Hemoglobin A2 (WG-HbA2), Determination of HbA2 by quantitative bottom-up proteomics and isotope dilution mass spectrometry, Clin. Chim. Acta, 487, 318, 10.1016/j.cca.2018.10.024 JRC website: https://ec.europa.eu/jrc/en. Paleari, 2010, On behalf of the IFCC working group on standardization of HbA2 (WG-HbA2), Towards the development of a certified reference material for hemoglobin A2, Clin. Chem. Lab. Med., 48, 1611, 10.1515/CCLM.2010.317 Paleari, 2012, Interlaboratory comparison of current high-performance methods for HbA2, Int. J. Lab. Haematol., 34, 362, 10.1111/j.1751-553X.2012.01403.x Paleari, 2018, Calibration by commutable control materials is able to reduce inter-method differences of current high-performance methods for HbA2, Clin. Chim. Acta, 477, 60, 10.1016/j.cca.2017.12.001 Kallner, 1999, The Stockholm consensus conference on quality specifications in laboratory medicine, 25–26 April 1999, Scand. J. Clin. Lab. Invest., 59, 475, 10.1080/00365519950185175 Sandberg, 2015, Defining analytical performance specifications: consensus statement from the 1st strategic conference of the European Federation of clinical chemistry and laboratory medicine, Clin. Chem. Lab. Med., 53, 833, 10.1515/cclm-2015-0067 Braga, 2015, Performance criteria for combined uncertainty budget in the implementation of metrological traceability, Clin. Chem. Lab. Med., 53, 905, 10.1515/cclm-2014-1240 Mosca, 2013, On behalf of the IFCC Working Group on Standardization of HbA2, Analytical goals for the determination of HbA2, Clin. Chem. Lab. Med., 51, 937, 10.1515/cclm-2012-0575 www.ifcchba1c.org. NHS Screening programmes, Sickle Cell and Thalassemia, II edition, September 2009. Mosca, 1989, An evaluation of the Diamat HPLC analyser for simultaneous determination of haemoglobins A2 and F, J. Autom. Chem., 11, 273, 10.1155/S1463924689000520 Tan, 1993, Evaluation of high performance liquid chromatography for routine estimation of haemoglobins A2 and F, J. Clin. Pathol., 46, 852, 10.1136/jcp.46.9.852 Craver, 1997, Hemoglobin A2 levels in healthy persons, sickle cell disease, sickle cell trait, and β-Thalassemia by capillary isoelectric focusing, Am. J. Clin. Pathol., 107, 88, 10.1093/ajcp/107.1.88 Rodriguez-Capote, 2015, Incidence of hemoglobinopathies and thalassemias in Northern Alberta. Establishment of reference intervals for HbF and HbA2, Clin. Biochem., 48, 698, 10.1016/j.clinbiochem.2015.04.001 Han, 2019, Reference intervals for HbA2 and HbF and cut-off value of HbA2 for β-thalassemia carrier screening in a Guizhou population of reproductive age, Clin. Biochem., 65, 24, 10.1016/j.clinbiochem.2018.11.007 Ceriotti, 2009, Reference intervals: the way forward, Ann. Clin. Biochem., 46, 8, 10.1258/acb.2008.008170 Koerbin, 2013, On behalf of the AACB Committee for Common Reference Intervals. Evidence-based approach to harmonised reference intervals, Clin. Chim. Acta Ceriotti, 2017, Quality specifications for the extra-analytical phase of laboratory testing: reference intervals and decision limits, Clin. Biochem., 50, 595, 10.1016/j.clinbiochem.2017.03.024